Back to Journals » Vascular Health and Risk Management » Volume 8

Metabolic syndrome and its components associated with endothelial dysfunction in chronic kidney disease patients

Authors Bai Q, Lai X, Zhang AH, Lu XH, Tian SL, Fan MH, Wang Y, Wang T

Received 18 October 2011

Accepted for publication 11 November 2011

Published 6 January 2012 Volume 2012:8 Pages 15—21

DOI https://doi.org/10.2147/VHRM.S27444

Review by Single-blind

Peer reviewer comments 3

Qiong Bai, Xuan Lai, Ai-Hua Zhang, Xin-Hong Lu, Shun-Li Tian, Min-Hua Fan, Yue Wang, Tao Wang
Division of Nephrology, Peking University Third Hospital, Beijing, People's Republic of China

Background: Cardiovascular disease is more common in patients with chronic kidney disease (CKD) than in the general population. Endothelial dysfunction is an early predictor of cardiovascular events.
Objective: We conducted a cross-sectional study in CKD patients to explore the association of metabolic syndrome (MetS) components with endothelial cell function.
Methods: We evaluated clinical and laboratory data in 161 CKD patients from stage 1 to stage 5. Endothelial function was estimated by flow-mediated dilatation (FMD) of the brachial artery and expressed as percentage change relative to baseline diameter. MetS was defined according to the National Cholesterol Education Program-Adult Treatment Panel III criteria.
Results: Patients were grouped into two groups according to whether or not they had MetS. FMD was significantly lower in the MetS group than in the group without MetS (P = 0.012). In a Pearson's correlation analysis, FMD was significantly negatively correlated with waist circumference in women (r = –0.223, P = 0.03) and fasting blood glucose (r = –0.186, P = 0.001). Multiple linear regression analysis showed that fasting blood glucose was an independently associated factor for FMD.
Conclusion: MetS and some components of MetS (waist circumference in women and fasting blood glucose) are closely associated with a decreased FMD in CKD patients.

Keywords: metabolic syndrome, endothelial dysfunction, flow-mediated dilatation, chronic kidney disease

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

A comparative cohort study of totally laparoscopic and open aortobifemoral bypass for the treatment of advanced atherosclerosis

Kazmi SS, Jørgensen JJ, Sundhagen JO, Krog AH, Flørenes TL, Kollerøs D, Abdelnoor M

Vascular Health and Risk Management 2015, 11:541-547

Published Date: 18 September 2015

Perceptions of barriers to cardiac rehabilitation use in Brazil

Ghisi GLM, Santos RZ, Aranha EE, Nunes AD, Oh P, Benetti M, Grace SL

Vascular Health and Risk Management 2013, 9:485-491

Published Date: 30 August 2013

Spanish translation, cross-cultural adaptation, and validation of the Questionnaire for Diabetes-Related Foot Disease (Q-DFD)

Castillo-Tandazo W, Flores-Fortty A, Feraud L, Tettamanti D

Vascular Health and Risk Management 2013, 9:501-508

Published Date: 28 August 2013

The prevention and regression of atherosclerotic plaques: emerging treatments

Kalanuria AA, Nyquist P, Ling G

Vascular Health and Risk Management 2012, 8:549-561

Published Date: 25 September 2012

Low body temperature associated with severe ischemic stroke within 6 hours of onset: The Bergen NORSTROKE Study

Kvistad CE, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2012, 8:333-338

Published Date: 1 June 2012